These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15202685)

  • 1. The contribution of small animal positron emission tomography to the neurosciences--a critical evaluation.
    Nikolaus S; Beu M; Wirrwar A; Vosberg H; Müller HW; Larisch R
    Rev Neurosci; 2004; 15(2):131-56. PubMed ID: 15202685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Receptor mapping in living human beings by means of positron emission tomography].
    Gjedde A
    Ugeskr Laeger; 2001 Sep; 163(38):5199-205. PubMed ID: 11577527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of receptors in clinical neurosciences.
    Korf J
    Acta Neurol Belg; 1997 Sep; 97(3):200-5. PubMed ID: 9345594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain receptor imaging.
    Heiss WD; Herholz K
    J Nucl Med; 2006 Feb; 47(2):302-12. PubMed ID: 16455637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography studies of brain receptors.
    Mazière B; Mazière M
    Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography studies on some neurotransmitter receptor systems with 6R-tetrahydrobiopterin pretreatment.
    Watanabe Y; Tani Y; Kanai T; Hartvig P; Inoue O; Andersson J; Lilja A; Långström B
    Adv Exp Med Biol; 1993; 338():321-6. PubMed ID: 8304129
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction to the conference. Positron emission tomography.
    Wagner HN
    J Neuropsychiatry Clin Neurosci; 1989; 1(1):S2-6. PubMed ID: 2535417
    [No Abstract]   [Full Text] [Related]  

  • 10. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation.
    Bauer A; Zilles K; Matusch A; Holzmann C; Riess O; von Hörsten S
    J Neurochem; 2005 Aug; 94(3):639-50. PubMed ID: 16033418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmitter receptor alterations in Parkinson's disease.
    Calne DB; Stoessl AJ
    Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation.
    Greitz T
    Adv Biochem Psychopharmacol; 1984; 39():69-78. PubMed ID: 6147069
    [No Abstract]   [Full Text] [Related]  

  • 14. PET: its clinical role in neurology.
    Brooks D
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):1-5. PubMed ID: 1672706
    [No Abstract]   [Full Text] [Related]  

  • 15. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease.
    Hume SP; Lammertsma AA; Myers R; Rajeswaran S; Bloomfield PM; Ashworth S; Fricker RA; Torres EM; Watson I; Jones T
    J Neurosci Methods; 1996 Aug; 67(2):103-12. PubMed ID: 8872875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurosciences. Their role in modern medicine].
    Vartanian ME
    Vestn Ross Akad Med Nauk; 1993; (7):3-6. PubMed ID: 7694707
    [No Abstract]   [Full Text] [Related]  

  • 17. Modeling dopamine system dysfunction in experimental animals.
    Hantraye P
    Nucl Med Biol; 1998 Nov; 25(8):721-8. PubMed ID: 9863556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological challenge and synaptic response - assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET).
    Nikolaus S; Larisch R; Vosberg H; Beu M; Wirrwar A; Antke C; Kley K; Silva MA; Huston JP; Müller HW
    Rev Neurosci; 2011; 22(6):625-45. PubMed ID: 22103308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
    Frost JJ
    Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic research strategies for imaging neurotransmitter systems.
    Snyder SH
    NIDA Res Monogr; 1986; 74():6-14. PubMed ID: 2892136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.